CD8A and COVID-19: More importantly, unlike the limited DTU and DTE changes shown in mild COVID-19 patients, significant changes were observed in severe COVID-19 patients across all cell types among PBMCs, including B cell, DC, CD4+ T cell, CD8+ T cell, monocyte and NK cell (Fig 5F).